CrossrefInfokarte
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study
European Journal of Cancer · 2026-11 · 248 · 117041
DOI: 10.1016/j.ejca.2026.117041 ↗Abstract
Kein Abstract verfügbar.
EUVIMED